Cannabis Strategic Ventures Inc. (NUGS) Inks MOU Outlining

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
345
Cannabis Strategic Ventures Inc. (NUGS) Inks MOU Outlining Strategic Acquisition of Indoor Cannabis Cultivation Facility

- Cannabis sales are projected to increase as NUGS makes move to increase premium cannabis production
- MOU grants rights for NUGS to purchase 10% of the facility at a valuation of $15 million for the entire facility
- Agreement strengthens company’s status as an emerging leader in the vertically integrated California cannabis marketplace

As sales of high-quality cannabis in California, the largest cannabis market in the country, are projected to increase, Cannabis Strategic Ventures (OTCQB: NUGS) is taking strategic steps to ensure its position in the growing space. Most recently, the company inked a Memorandum of Understanding with Devine Solution Inc. with the end goal of increasing its cannabis production capacity (https://nnw.fm/9rNqr).

“Sales of legal adult-use cannabis are expected to increase greatly in the state of California between 2018 and 2024,” reported Statista (https://nnw.fm/EPebx). “Sales already reached 2.5 billion U.S. dollars in 2018 (the largest U.S. market) and are expected to grow to roughly 7.2 billion by 2024.”

Cannabis Strategic Ventures is aligning its long-term strategy with that growth in mind, as the company remains focused on shaping the future of the cannabis industry by striving for constant evolution in products, places and people. The MOU outlines NUGS’ plans relating to its proposed acquisition of an indoor cannabis cultivation facility owned by California-based Devine. Based on the terms of the recently signed MOU, NUGS is moving forward to purchase 10% of the facility at a valuation of $15 million for the entire facility; the agreement includes an option to purchase an additional 41% of the facility (which would comprise a controlling 51% stake) at this same valuation, which would results in a controlling 51% stake for Cannabis Strategic Ventures.

“This deal represents the potential to sharply increase our premium cannabis production capacity and materially augment our status as an emerging leader in the vertically integrated California cannabis marketplace,” said NUGS CEO Simon Yu. “We have already amassed years of experience refining our cultivation methods and strains in an outdoor framework with our NUGS Farm North site. Adding a top-tier indoor cultivation operation stands to help us further build upon that success and drive more volume in the premium flower market, which has powerful implications given our recent expansion into the dispensary marketplace with our MDRN Tree downtown LA dispensary location. The combination grants NUGS expanding operations at both ends of the farm-to-sale model.”

The 15,600-square foot facility is located in Sacramento, California, and has the potential to house an estimated 500 grow lights. The existing infrastructure has the potential to produce up to three pounds of premium exotic cannabis flower per light per harvest, with a projected 5.75 harvests per year. That would mean the potential for more than 7,000 pounds of premium cannabis flower per year for NUGS, which is one of the largest publicly traded marijuana cultivators in the United States.

Cannabis Strategic Ventures also has a wholly owned subsidiary — NUGS Farm North — that is a fully state legal licensed Cannabis cultivator in the state of California. The property has more than six acres of greenhouse. Cannabis Strategic Ventures cultivates and sells cannabis biomass and related cannabis products to the legal cannabis market.

For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Aurelia Cellular Vitality Launch: Beauty Supplements Shake Up U.S. Market

Updated Category News Views 171

Aurelia Cellular Vitality just hit the U. S. market on February 17, 2026, and this ain't just another beauty brand strutting in with flashy ads and pretty bottles. They’re packing some serious science behind their hair, skin, and nail supplements formulated with their proprietary Eternacell™ complex designed to hit cellular-level vitality hard—think anti-aging but...

Continue Reading
Upcoming Financial Results Announcement for EWCZ

Updated Category News Views 117

Exciting Developments Ahead for European Wax Center, Inc. European Wax Center, Inc. (NASDAQ: EWCZ), recognized as a prominent franchisor specializing in out-of-home waxing services across the United States, is gearing up to unveil significant financial reports. Anticipation builds as the company prepares to disclose its fourth-quarter and fiscal year 2024 financial...

Continue Reading
Revolutionizing Nutritional Understanding Through Innovative Science

Updated Category News Views 138

A Comprehensive Look at Nutrient Intake Measurement A recent innovative framework designed to measure nutrient absorption offers a new perspective on how we understand the nutrients our bodies utilize. Traditional methods often focus solely on the total nutrient content, neglecting a crucial factor in nutrient intake: how much of those nutrients are actually absorbed by...

Continue Reading
Jennifer Cable Joins J2 Ventures Advisory Board to Drive Innovation

Updated Category News Views 168

Back in the day, Jennifer Cable took the reins as President of Thorlabs, positioning herself at the forefront of optical technology. Fast forward to her latest move—she joined J2 Ventures' advisory board, which sent ripples through the deep tech landscape. Traders were buzzing; they knew this wasn’t just another face in the crowd. With over $250 million under...

Continue Reading
Unlocking Monthly Income with Bank of America Dividends

Updated Category News Views 101

Understanding Bank of America Stock Dividends Bank of America Corporation (NASDAQ: BAC) is set to announce its earnings for the second quarter soon, generating buzz among investors regarding its dividend potential. Its current annual dividend yield stands at 2.20%, which translates to a quarterly dividend of 26 cents per share or $1.04 annually. Calculating Monthly Income...

Continue Reading